One-year results of the intrascleral glaucoma implant.
This is an initial report from a study to determine the safety and efficacy of an implant placed within the sclera to relieve elevated intraocular pressure (IOP). It describes the first eight patients to receive the implant. Intraocular pressure and pneumotonometry were evaluated preoperatively and postoperatively for one year. In five patients, IOP decreased. Three patients in which the implant was considered a failure because of wound leaks had patch grafts, removal of the implant, or both. The five successful cases have continued to show reduced IOP.
Wills Eye Hospital, Philadelphia, Pennsylvania, USA.
S G
SG
Smith
J C
JC
Galanis
D001082:Aqueous Humor / Q000378:metabolism; D001672:Biocompatible Materials; D005901:Glaucoma / Q000601:surgery*; D006801:Humans; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D007429:Intraocular Pressure; D010865:Pilot Projects; D011092:Polyethylene Glycols; D011379:Prognosis; D019736:Prostheses and Implants; D012590:Sclera / Q000601:surgery*; D014945:Wound Healing
D001672:Biocompatible Materials; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D011092:Polyethylene Glycols